Feasibility of five days of consecutive leukocytapheresis for the treatment of ulcerative colitis: A preliminary study

Therapeutic Apheresis and Dialysis

Volumn 13, Issue 1, 2009, Pages 14-18

  Tsujikawa, Tomoyuki ^a   Andoh, Akira ^a   Ogaẃa, Atsuhiro ^a   Sonoda, Ayano ^a   Yagi, Yuhki ^a   Hata, Kazuori ^a   Sasaki, Masaya ^b   Saito, Yasaharu ^b   Fujiyama, Yoshihide ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE HOSPITAL   (Japan)

Author keywords

Leukocytapheresis; Thrombocytopenia; Ulcerative colitis

Indexed keywords

HEMOGLOBIN;

ADULT; ARTICLE; BLOOD VOLUME; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; FEASIBILITY STUDY; FEMALE; GASTROINTESTINAL ENDOSCOPY; GENERAL CONDITION IMPROVEMENT; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; LEUKAPHERESIS; MALE; PRIORITY JOURNAL; REMISSION; THERAPY EFFECT; THROMBOCYTE COUNT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; COLITIS, ULCERATIVE; COLONOSCOPY; FEMALE; GLUCOCORTICOIDS; HEMOGLOBINS; HUMANS; LEUKAPHERESIS; MALE; PILOT PROJECTS; PLATELET COUNT; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 62149135619     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2009.00650.x     Document Type: Article

References (12)

1. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002 347 : 417 29.
2. Dujovne CA, Azarnoff DL. Clinical complications of corticosteroid therapy. A selected review. Med Clin North Am 1973 57 : 1331 42.
3. Sawada K, Ohnishi K, Kosaka T et al. Leukocytapheresis therapy with leukocyte removal filter for inflammatory bowel disease. J Gastroenterol 1995 30 : 124 7.
4. Shimoyama T, Sawada K. Prospective multicenter randomized trial for treatment of ulcerative colitis by leukocytapheresis therapy with leukocyte removal filter. In : Shimoyama T, ed. Annual report of the Research Committee of Inflammatory Bowel Disease. Tokyo : Ministry of Health and Welfare of Japan, 1998 126 9.
5. Nishioka C, Aoyama N, Maekawa S et al. Leukocytapheresis therapy for steroid-naïve patients with active ulcerative colitis: its clinical efficacy and adverse effects compared with those of conventional steroid therapy. J Gastroenterol Hepatol 2005 20 : 1567 71.
6. Kanke K, Nakano M, Hiraishi H, Terano A. Clinical evaluation of granulocyte/monocyte apheresis therapy for active ulcerative colitis. Dig Liver Dis 2004 36 : 811 17.
7. Shibata H, Kuriyama T, Yamawaki N. Cellsorba. Ther Apher Dial 2003 7 : 44 7.
8. Lichtiger S, Present DH, Kornbluth A et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994 330 : 1841 5.
9. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ 1989 298 : 82 6.
10. Sawada K, Muto T, Shimoyama T et al. Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column. Curr Pharm Des 2003 9 : 307 21.
11. Yamaji K, Yang K, Tsuda H, Hashimoto H. Fluctuations in the peripheral blood leukocyte and platelet counts in leukocytapheresis in healthy volunteers. Ther Apher 2002 6 : 402 12.
12. D'Haens G, Lemmens L, Geboes K et al. Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis. Gastroenterology 2001 120 : 1323 9.